ASIA unversity:Item 310904400/101621
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94286/110023 (86%)
造訪人次 : 21710480      線上人數 : 384
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/101621


    題名: Association between antiepileptic drugs and hepatocellular carcinoma in patients with epilepsy: a population- based case–control study
    作者: Dong-Zong Hung;Cheng-Li Lin;Yi-Wen Li;Yen-Ning Lin;Ying-Ray Lee;王昭能;Charles-C. N. Wang;Jih-Jung Chen;Yun-Ping Lim
    貢獻者: 生物資訊與醫學工程學系
    日期: 2016-09
    上傳時間: 2016-11-08 02:17:58 (UTC+0)
    摘要: Background

    This study explored whether antiepileptic drugs (AEDs) use increases the risk of hepatocellular carcinoma (HCC).
    Methods

    We conducted a case–control study using data from the National Health Insurance system of Taiwan. The case group comprised 1,454 epilepsy patients with newly diagnosed HCC, and the control group comprised 1,448 epilepsy patients without HCC. Both groups had similar distributions of sex and age, and follow-up duration. Possible associations with the AEDs in Taiwan were examined.
    Results

    After adjusted for AEDs (phenobarbital and primidone, clonazepam, clorazepate and diazepam, and other AEDs), and for the comorbidities of diabetes, chronic liver disease and cirrhosis, hepatitis B and C virus infection, and alcoholism, the odds ratio (OR) of HCC was 1.22 (95% confidence interval [CI]: 1.01–1.47) for the group of phenytoin users compared with nonphenytoin users. An annual means of 61–120, 121–180, and >180 of defined daily doses (DDDs) of phenytoin (OR: 4.07, 95% CI: 2.03–8.18; OR: 7.51, 95% CI: 3.03–18.7, and OR: 14.6, 95% CI: 7.88–26.9, respectively) were significantly correlated with the risk of HCC but not with a DDD of ≤60. Compared with nonphenytoin users, HCC patients who had used phenytoin within 1 year of HCC diagnosis were at a greatest risk of HCC (adjusted OR: 2.29, 95% CI: 1.71–3.08), followed by who had used phenytoin within 2 years of diagnosis (adjusted OR: 1.92, 95% CI: 1.44–2.56).
    Conclusion

    The results indicate that high dose of phenytoin was associated with a statistically significant increased OR for HCC, which was not demonstrated for low-dose phenytoin.
    關聯: Brain and Behavior
    顯示於類別:[生物資訊與醫學工程學系 ] 期刊論文

    文件中的檔案:

    檔案 大小格式瀏覽次數
    index.html0KbHTML339檢視/開啟


    在ASIAIR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋